Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer

A Naik; J Decock

doi:10.3389/fonc.2023.1115620

Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer

Front Oncol. 2023 Feb 6:13:1115620. doi: 10.3389/fonc.2023.1115620. eCollection 2023.

Authors

A Naik¹, J Decock^{1

2}

Affiliations

¹ Translational Cancer and Immunity Center (TCIC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
² College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.

No abstract available

Keywords: LDHC; cancer biomarker; cancer testis antigen; lactate dehydrogenase C; therapeutic target.

Publication types

Comment

Grants and funding

This work was supported by a grant from the Qatar Biomedical Research Institute (#VR94), awarded to JD. Open Access funding provided by the Qatar National Library.